Trade Loncar Cancer Immunotherapy ETF - CNCR CFD
Add to favourite- Summary
- Historical Data
- Events
| Spread | 0.24 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
| Prev. Close* | 14.18 |
| Open* | 14.29 |
| 1-Year Change* | 9.5% |
| Day's Range* | 14.29 - 14.62 |
| 52 wk Range | N/A |
| Average Volume (10 days) | N/A |
| Average Volume (3 months) | N/A |
| Market Cap | N/A |
| P/E Ratio | N/A |
| Shares Outstanding | N/A |
| Revenue | N/A |
| EPS | N/A |
| Dividend (Yield %) | N/A |
| Beta | N/A |
| Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 22, 2024 | 14.18 | 0.09 | 0.64% | 14.09 | 14.33 | 13.96 |
| Apr 19, 2024 | 14.11 | -0.06 | -0.42% | 14.17 | 14.38 | 13.82 |
| Apr 18, 2024 | 14.35 | -0.03 | -0.21% | 14.38 | 14.60 | 14.17 |
| Apr 17, 2024 | 14.53 | -0.15 | -1.02% | 14.68 | 14.82 | 14.46 |
| Apr 16, 2024 | 14.65 | -0.22 | -1.48% | 14.87 | 14.96 | 14.58 |
| Apr 15, 2024 | 15.02 | -0.39 | -2.53% | 15.41 | 15.41 | 14.97 |
| Apr 12, 2024 | 15.37 | -0.28 | -1.79% | 15.65 | 15.74 | 15.21 |
| Apr 11, 2024 | 15.80 | 0.23 | 1.48% | 15.57 | 15.87 | 15.55 |
| Apr 10, 2024 | 15.56 | 0.15 | 0.97% | 15.41 | 15.57 | 15.30 |
| Apr 9, 2024 | 15.84 | 0.33 | 2.13% | 15.51 | 15.93 | 15.51 |
| Apr 8, 2024 | 15.46 | 0.04 | 0.26% | 15.42 | 15.53 | 15.41 |
| Apr 5, 2024 | 15.49 | 0.13 | 0.85% | 15.36 | 15.58 | 15.25 |
| Apr 4, 2024 | 15.50 | -0.26 | -1.65% | 15.76 | 16.03 | 15.33 |
| Apr 3, 2024 | 15.62 | 0.14 | 0.90% | 15.48 | 15.67 | 15.48 |
| Apr 2, 2024 | 15.70 | -0.08 | -0.51% | 15.78 | 15.87 | 15.50 |
| Apr 1, 2024 | 16.32 | -0.16 | -0.97% | 16.48 | 16.48 | 16.01 |
| Mar 28, 2024 | 16.45 | 0.17 | 1.04% | 16.28 | 16.62 | 16.27 |
| Mar 27, 2024 | 16.29 | 0.42 | 2.65% | 15.87 | 16.37 | 15.72 |
| Mar 26, 2024 | 15.76 | -0.06 | -0.38% | 15.82 | 16.00 | 15.71 |
| Mar 25, 2024 | 15.76 | -0.29 | -1.81% | 16.05 | 16.22 | 15.65 |
Loncar Cancer Immunotherapy ETF Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Loncar Cancer Immunotherapy ETF Company profile
The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index.News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com